PCDH10 Activators comprises a group of compounds and molecules that have been identified for their potential to modulate the activity of the PCDH10 (Protocadherin-10) protein. PCDH10 belongs to the protocadherin family of cell adhesion molecules, and it plays a crucial role in various biological processes, particularly in neural development, synaptic plasticity, and cell-cell adhesion. As part of this class, these activators are recognized for their ability to influence PCDH10's function either directly or indirectly.
Direct activators within this class may interact with PCDH10 at the molecular level, enhancing its adhesive properties or regulating its downstream signaling pathways. These activators can potentially promote neural development, synaptic plasticity, and the maintenance of neural connections by facilitating PCDH10's role in cell adhesion and intercellular communication. On the other hand, indirect activators may influence PCDH10 by targeting signaling pathways and cellular processes that intersect with or impact PCDH10-related functions. For example, compounds that elevate intracellular cyclic AMP (cAMP) levels or increase intracellular calcium may indirectly affect PCDH10 through their impact on downstream signaling pathways. Understanding and characterizing these PCDH10 activators is of great interest in basic research and neuroscience, as they provide tools to probe the complex mechanisms that underlie neural development and synaptic plasticity, shedding light on the intricate web of interactions within the brain's intricate network of cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Indirectly influences PCDH10 by elevating intracellular cAMP levels, potentially impacting PCDH10 through cAMP-dependent pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Indirectly influences PCDH10 by increasing intracellular calcium levels, potentially affecting PCDH10 through calcium-dependent pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
An indirect activator that influences PCDH10 via cAMP-dependent signaling pathways when cAMP levels are elevated. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Indirectly activates PCDH10 by activating protein kinase C (PKC), which is involved in various signaling pathways associated with PCDH10. | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
Directly influences PCDH10 through NMDA receptor activation, a mechanism linked to synaptic plasticity and neural development. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
An indirect activator of PCDH10 by inhibiting phosphoinositide 3-kinase (PI3K), which can impact downstream signaling pathways related to PCDH10. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
A compound studied for its potential effects on signaling pathways associated with neural development and mood regulation, which may indirectly influence PCDH10 by impacting related pathways. | ||||||